Thursday, January 29, 2009

Gern finally recovered past our purchase price

7.69 was our buy. Tradeable and one you could put away for a year. Today a competator anounced rats paralazied made dramatic improvements with stem cell use. This thing is years away with the first humans starting this summer to there response with stem cells. I have a list of 10 biotechs I chart and watch. I'll post em later. There all speculative picks. Not DNA genentec of the big cap proven winners group. SPECULATIVE by the way my spell check doesnt compute hear on blogger